In adults with T1D, Baqsimi also demonstrated a shorter time to achieve treatment success compared to Gvoke; however, the analysis did not reach statistical significance (treatment difference: 1.04 min, 95% credible interval [− 0.24, 2.34]).
← all excerpts
Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia.
1
—
—